Olivier Neyrolles Selected Research

DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)

1/2018	The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to Mycobacterium tuberculosis.
7/2010	C-type lectins in immune defense against pathogens: the murine DC-SIGN homologue SIGNR3 confers early protection against Mycobacterium tuberculosis infection.
11/2007	Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients.
2/2007	Length variation of DC-SIGN and L-SIGN neck-region has no impact on tuberculosis susceptibility.
9/2006	Towards a crucial role for DC-SIGN in tuberculosis and beyond.
2/2006	Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis.
1/2006	DC-SIGN interacts with Mycobacterium leprae but sequence variation in this lectin is not associated with leprosy in the Pakistani population.
12/2005	Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity.
12/2005	DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis.
2/2003	The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Neyrolles Research Topics

Disease

52	Tuberculosis (Tuberculoses) 01/2021 - 01/2003
31	Infections 01/2022 - 03/2004
3	Coinfection 11/2022 - 01/2020
3	Neoplasms (Cancer) 12/2020 - 01/2011
3	Pleural Effusion (Pleural Effusions) 10/2020 - 01/2018
3	Communicable Diseases (Infectious Diseases) 01/2019 - 09/2006
3	Poisoning 03/2015 - 09/2011
2	Inflammation (Inflammations) 01/2022 - 01/2017
2	Pneumonia (Pneumonitis) 01/2022 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2020
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020 - 01/2011
2	Granuloma 12/2015 - 01/2012
1	COVID-19 01/2022
1	HIV Infections (HIV Infection) 01/2021
1	Pleural Tuberculosis 12/2020
1	Colonic Neoplasms (Colon Cancer) 12/2020
1	Human Influenza (Influenza) 11/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Dysbiosis 01/2018
1	Bites and Stings (Sting) 01/2018
1	Hypoxia (Hypoxemia) 11/2017
1	Disease Progression 12/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2015
1	Colitis 04/2015
1	Staphylococcal Infections 03/2015

Drug/Important Bio-Agent (IBA)

11	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2018 - 01/2003
9	CytokinesIBA 01/2022 - 02/2003
6	LectinsIBA 01/2020 - 01/2003
6	C-Type Lectins (C-Type Lectin)IBA 01/2020 - 12/2005
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2003
5	VaccinesIBA 01/2020 - 02/2003
4	LipidsIBA 12/2020 - 12/2006
4	InterleukinsIBA 10/2020 - 03/2004
4	LigandsIBA 01/2020 - 02/2003
4	NitrogenIBA 11/2014 - 03/2004
3	Interferon Type IIBA 01/2022 - 01/2017
3	InterferonsIBA 01/2022 - 01/2012
3	AntigensIBA 03/2016 - 12/2005
3	Biological ProductsIBA 08/2015 - 03/2004
3	ZincIBA 03/2015 - 09/2011
3	Mannose (D-Mannose)IBA 01/2015 - 02/2003
3	lipoarabinomannan (LAM)IBA 01/2015 - 02/2003
3	MicroRNAs (MicroRNA)IBA 05/2014 - 01/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 03/2004
2	InflammasomesIBA 01/2022 - 03/2015
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 12/2005
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020 - 01/2018
2	Pattern Recognition ReceptorsIBA 01/2020 - 01/2011
2	AntitoxinsIBA 01/2020 - 01/2020
2	Trinitrotoluene (TNT)IBA 01/2020 - 01/2019
2	Interleukin-12 (IL 12)IBA 02/2018 - 01/2017
2	HLA-DR Antigens (HLA-DR)IBA 02/2018 - 01/2003
2	Virulence Factors (Pathogenicity Factors)IBA 10/2017 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 12/2015 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2015 - 05/2013
2	CopperIBA 03/2015 - 03/2012
2	Aspartic Acid (Aspartate)FDA Link 03/2014 - 11/2013
2	Attenuated VaccinesIBA 09/2010 - 01/2009
1	Antiviral Agents (Antivirals)IBA 11/2022
1	Antimicrobial PeptidesIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	MucinsIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Cystatin CIBA 01/2021
1	CystatinsIBA 01/2021
1	STAT6 Transcription FactorIBA 10/2020
1	Imipenem FDA Link 01/2020
1	EpitopesIBA 01/2020
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2020
1	bedaquiline (R207910)IBA 01/2020
1	Sialic Acid Binding Ig-like Lectin 1IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Bacterial ToxinsIBA 01/2020
1	3-methoxybutylcyanoacrylateIBA 01/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2019
1	EnzymesIBA 01/2019
1	ChemokinesIBA 02/2018
1	Chemokine CCL5IBA 02/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	BCG Vaccine FDA Link 01/2018
1	STAT1 Transcription FactorIBA 01/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	NitratesIBA 11/2017
1	molybdopterin (molybdenum cofactor)IBA 11/2017
1	Oxygen (Dioxygen)IBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 10/2017
1	CathepsinsIBA 01/2016
1	c-Mer Tyrosine KinaseIBA 12/2015
1	Staphylococcal Protein A (Protein A)IBA 04/2015
1	ManganeseIBA 03/2015
1	CationsIBA 03/2015
1	IronIBA 03/2015
1	MetalsIBA 03/2015
1	Messenger RNA (mRNA)IBA 05/2014
1	Essential Amino AcidsIBA 03/2014

Therapy/Procedure

8	Therapeutics 01/2020 - 01/2012
1	Immunotherapy 12/2020